Clinical Trials List
2011-09-01 - 2013-12-31
Others
Terminated4
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yu-Min Yeh Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Liu Yi-Sheng Division of Radiology
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- 呂佳興 Division of Radiology
- Peng-Chan Lin Division of Hematology & Oncology
- 邱彥程 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 許金川 Division of General Internal Medicine
- Ying-Chun Shen Division of Hematology & Oncology
- Chien-Hung Chen Division of General Internal Medicine
- 黃冠棠 Division of General Internal Medicine
- - - Division of Radiology
- Ann-Lii Cheng Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yi-Hsiang Huang Digestive System Department
- Chien-An Liu Division of Radiology
- Ming-Huang Chen Division of Hematology & Oncology
- Chien-Wei Su Digestive System Department
- Chung-Pin Li Digestive System Department
- Rheun-Chuan Lee Division of Radiology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 林明賢 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 馮盈勳 Division of Hematology & Oncology
- 陳威宇 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
120 participants